` VINEETLAB (Vineet Laboratories Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

VINEETLAB
vs
B
BSE Sensex 30

Over the past 12 months, VINEETLAB has underperformed BSE Sensex 30, delivering a return of -18% compared to the BSE Sensex 30's +6% growth.

Stocks Performance
VINEETLAB vs BSE Sensex 30

Loading
VINEETLAB
BSE Sensex 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VINEETLAB vs BSE Sensex 30

Performance Gap Between VINEETLAB and BSESN
HIDDEN
Show

Performance By Year
VINEETLAB vs BSE Sensex 30

Loading
VINEETLAB
BSE Sensex 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Vineet Laboratories Ltd vs Peers

BSE Sensex 30
VINEETLAB
JEF
JNJ
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Vineet Laboratories Ltd
Glance View

Market Cap
619.7m INR
Industry
Pharmaceuticals

Vineet Laboratories Ltd. specializes in pharmaceutical intermediates and fine chemicals. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-06-15. The firm is specialized in manufacturing pharmaceutical intermediates and fine chemicals. The firm is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium, Isopropyl-beta-D-thiogalactopyranoside (IPTG), 4-Nitrophenyl phosphate disodium salt (PNPP), 4-Chlorobutyryl chloride, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, n-Butylnitrite, Ethyldiazo acetate, Phenylboronic acid, Dimethyl phenoxy acetyl chloride and Piroctone Olamine.

VINEETLAB Intrinsic Value
HIDDEN
Show
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett